Dr. Ch Srivalli
Dr. Ch. Srivalli is a highly accomplished Consultant Medical Oncologist with an outstanding academic background and a strong commitment to patient-centric cancer care. She completed her MBBS from Kamineni Institute of Medical Sciences in 2015, where she excelled consistently and received multiple gold medals at both college and university levels. She was also recognized as the Best Outgoing Student of the 2009–2015 batch and the Best Outgoing Student in Final MBBS statewide, reflecting her dedication and excellence in medical education.
Following this, she pursued her MD in General Medicine at Kasturba Medical College, MAHE, Manipal, one of India’s premier medical institutions. Her academic journey further progressed with a DrNB in Medical Oncology from NBEMS, where she was awarded the President’s Gold Medal, a prestigious recognition for her exceptional performance and expertise.
Dr. Srivalli brings with her over five years of experience in managing and treating a wide spectrum of cancers, including lung, colorectal, breast, and hematologic malignancies. She is skilled in administering chemotherapy as well as advanced treatment modalities such as targeted therapies and immunotherapy protocols, ensuring patients receive the latest evidence-based care.
Her clinical philosophy emphasizes a compassionate, patient-centric approach, where every individual is treated with empathy, dignity, and respect. She is deeply committed to providing evidence-based, holistic, and personalized oncology care aimed at improving survival outcomes and enhancing quality of life.
In addition to her clinical expertise, Dr. Srivalli has also contributed to academic research. She co-authored the study: “Role of CA125 in predicting pathological response and recurrence in advanced stage non-mucinous epithelial ovarian cancer” published in the International Journal of Reproduction, Contraception, Obstetrics and Gynecology (2022).
With her blend of academic brilliance, clinical skill, and compassionate outlook, Dr. Ch. Srivalli is dedicated to guiding patients and families through their cancer journey with hope, advanced treatment, and unwavering care.
Ch Srivalli, Gangadharan VP, Anupama G. Role of CA125 in predicting pathological response and recurrence in advanced stage non-mucinous epithelial ovarian cancer.
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2022; 11:3087–92.